Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|26|2734-2748

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.26, 2007-11, pp. : 2734-2748

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure Based Design of Inhibitors of Aspartic Protease of HIV-1

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 8, 2005-12 ,pp. : 638-646

Bentham Science Publishers

Access to resources Recommend Favorite

Current Development on HIV-1 Protease Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 3, Iss. 3, 2007-09 ,pp. : 201-213

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 protease inhibitors in development

By Catamancio Simona La Seta   Rusconi Stefano  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 387-395

Informa Healthcare

Access to resources Recommend Favorite

HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. : 1905-1922

Bentham Science Publishers

Access to resources Recommend Favorite

Heterocyclic HIV-Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. : 3693-3710

Bentham Science Publishers

Access to resources Recommend Favorite